reviewThe LancetOct 1, 2005Closed access

Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis

LLLars LindholmBCBo CarlbergOSOla Samuelsson

Umeå University · Sahlgrenska University Hospital

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

991
total citations
FWCI
72.55
Percentile
100%
References
49
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • Meta-analysis
  • Medicine
  • Adrenergic beta-Antagonists
  • MEDLINE
  • Primary (astronomy)
  • Internal medicine
  • Political science
  • Propranolol
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.